Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: Restoration by local granulocyte macrophage - Colony-stimulating factor gene transfer

Blood

Volumn 99, Issue 4, 2002, Pages 1246-1252

  Santosuosso, Michael ^a   Divangahi, Maziar ^a   Zganiacz, Anna ^a   Xing, Zhou ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DNA VECTOR; GENE EXPRESSION; GENE TRANSFER; GRANULOCYTOPENIA; IMMUNITY; INFECTION SENSITIVITY; LEUKOCYTE COUNT; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

EID: 0037082465     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1246     Document Type: Article

References (41)

1. The impact of pulmonary infections on the survival of lung cancer patients
2. The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital
3. Approach to the patient with pulmonary infections
4. Cytokine mediators of septic infections in the normal and granulocytopenic host
5. Poly's lament: The neglected role of the PMN in the afferent limb of the immune response
6. Cytokine expression by neutrophils and macrophages in vivo: Endotoxin induces TNF-α, MIP-2, IL-1β and IL-6 but not RANTES or TGF-β1 mRNA expression in acute lung inflammation
7. Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice
8. Protective effect of granulocyte colony-stimulating factor in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-α) production
9. The effect of treatment with interleukin-1 and tumour necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model
10. MIP-1 atpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts
11. Molecular immunobiology of macrophages: Recent progress
12. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection
13. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa
14. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia
15. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival
16. Cell kinetics of pulmonary alveolar macrophages in the mouse
17. The cytokinetic behavior of pulmonary alveolar macrophages in monocytopenic mice
18. Self-renewal of pulmonary alveolar macrophages: Evidence from radiation and chimera studies
19. Alveolar macrophages
20. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis and fibrotic reactions
21. Transgenic expression of GM-CSF induces the differentiation and activation of a novel dendritic cell population in the lung
22. Cytokine and eosinophil responses in the lung, peripheral blood and bone marrow compartments in a murine model of allergen-induced airways inflammation
23. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice
24. Human upper airway structural cell-derived cytokines support human peripheral blood monocyte survival: A potential mechanism for monocyte/macrophage accumulation in the tissue
25. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities
26. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction
27. Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation
28. Adenovirus-mediated cytokine gene transfer at tissue sites: Overexpression of IL-6 induces lymphocytic hyperplasia in the lung
29. Adenoviral vector-mediated interleukin-10 expression in vivo: Intramuscular gene transfer inhibits cytokine responses in endotoxemia
30. Current understanding of macrophage type 1 cytokine responses during intracellular infections
31. Granulocyte-macrophage colony-stimulating factor: Pleiotropic cytokine with potential clinical usefulness
32. Emerging applications of recombinant human GM-CSF
33. Highdose cyclophosphamide therapy for malignant disease
34. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice
35. Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy
36. Cytokine-mobilized peripheral blood progenitor cells
37. Aerosol granulocyte macrophage-colony stimulating factor: A low-toxicity, lung-specific biological therapy in patients with lung metastases
38. Results of a randomized trial of GM-CSF I patients with infection and severe granulocytopenia
39. Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamidedoxorubicin-etoposide using GM-CSF with or without antimicrobial prophylaxis in patients with small-cell lung cancer
40. Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA
41. Cyclophosphamide (Cytoxan): A review on relevant pharmacology and clinical uses